decisionhealth Newsletters, Part B News - 2013 Issue 12 (December)
Look for heparin, B12 jumps in otherwise stable Q1 2014 drug prices
Subscribe or sign in to view the full article.
Article Overview
This article summarizes quarterly drug pricing changes reported through CMS for Q1 2014 and highlights which commonly used injectable, oral, vaccine, and related products saw the most notable movement. It is intended for coding, billing, reimbursement, pharmacy, and provider-office audiences that track ASP-based payment updates and drug list changes.
Why This Topic Matters
ASP updates can affect reimbursement calculations and billing workflows for practices, clinics, labs, and outpatient facilities. The article helps readers identify which drug price changes and list revisions may be most relevant to their operations.
Article Sections
-
Drug pricing
Overview of the quarterly CMS average sales price update and why the pricing list is used for reimbursement-related payment review.
-
Changes to commonly used drugs in Q1 2014 ASP
Tabulated summary of selected drug price movements, including increases, decreases, and the quarterly pricing comparison used in the article.
What You Will Learn
- What the article covers in the Q1 2014 CMS ASP update
- Which broad categories of drugs experienced notable pricing movement
- How quarterly ASP changes relate to provider reimbursement tracking
- What kinds of drug list additions and removals were reported for the quarter
Who Should Read This
- Medical coders
- Billing staff
- Reimbursement specialists
- Pharmacy staff
- Clinic and ASC administrators
- Laboratory billing teams
Codes Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com